Table 3.
Single parathyroid gland | Group B | Group C | Group A | Significance group B vs. group C |
---|---|---|---|---|
Sensitivity: ultrasound | 84 % | 71 % | 78 % | n.s. |
Specificity: ultrasound | 94 % | 93 % | 94 % | n.s. |
Accuracy: ultrasound | 91 % | 87 % | 89 % | n.s. |
Prevalence: ultrasound | 28 % | 28 % | 28 % | n.s. |
Positive predictive value (PPV) ultrasound | 85 % | 79 % | 82 % | n.s. |
Nuclear medicine (%) | Nuclear medicine (%) | Nuclear medicine (%) | Significance group B vs. group C |
|
---|---|---|---|---|
Sensitivity: scintigraphy | 71 | 73 | 72 | n.s. |
Specificity: scintigraphy | 90 | 90 | 90 | n.s. |
Accuracy: scintigraphy | 85 | 85 | 85 | n.s. |
Prevalence: scintigraphy | 28 | 28 | 28 | n.s. |
Positive predictive value (PPV) scintigraphy |
74 | 73 | 74 | n.s. |
Overall sensitivity (use of both methods “in parallel”) | 88 | 87 | 88 | |
Positive predictive value (PPV) ultrasound vs. scintigraphy |
n.s. | n.s. | <0.05 |
Side (right/left) | Group B (%) | Group C (%) | Group A (%) | Significance group B vs. group C |
---|---|---|---|---|
Sensitivity: ultrasound | 91 | 78 | 85 | n.s. |
Specificity: ultrasound | 95 | 93 | 94 | n.s. |
Accuracy: ultrasound | 93 | 85 | 89 | n.s. |
Prevalence: ultrasound | 53 | 52 | 53 | n.s. |
Positive predictive value (PPV) ultrasound |
95 | 93 | 94 | n.s. |
Nuclear medicine (%) | Nuclear medicine (%) | Nuclear medicine (%) | Significance group B vs. group C |
|
---|---|---|---|---|
Sensitivity: scintigraphy | 77 | 80 | 78 | n.s. |
Specificity: scintigraphy | 88 | 84 | 86 | n.s. |
Accuracy: scintigraphy | 82 | 82 | 82 | n.s. |
Prevalence: scintigraphy | 53 | 52 | 53 | n.s. |
Positive predictive value (PPV) scintigraphy |
88 | 85 | 86 | n.s |
Overall sensitivity (use of both methods “in parallel”) | 95 | 92 | 94 | |
Positive predictive value (PPV) ultrasound vs. scintigraphy |
n.s. | n.s. | n.s. |